Maleic acid
Showing 1 - 25 of 8,005
Root Canal Infection, Periapical Abscess, Irreversible Pulpitis Trial in Karachi (Ethylene Diamine Tetra Acetic acid, smearOFF,
Active, not recruiting
- Root Canal Infection
- +3 more
- Ethylene Diamine Tetra Acetic acid
- +3 more
-
Karachi, Sindh, PakistanDow University of Health Sciences
Mar 18, 2023
Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)
Active, not recruiting
- Metastatic Cancer
- HER2 Gene Mutation
- Neratinib Maleate
-
Seoul, Korea, Republic ofKorea university Guro hospital
Oct 18, 2023
HER2-positive Breast Cancer Trial in Nanjing (Pyrotinib)
Recruiting
- HER2-positive Breast Cancer
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 26, 2023
COPD Trial (HRG2005 inhalation, Placebo to match HRG2005 inhalation, Placebo to match Indacaterol Maleate and Glycopyrronium
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- HRG2005 inhalation
- +3 more
- (no location specified)
Sep 7, 2023
NSCLC Trial (Sutetinib Maleate Capsule)
Not yet recruiting
- Non-small Cell Lung Cancer
- Sutetinib Maleate Capsule
- (no location specified)
Aug 18, 2023
HER2-positive Recurrent/Metastatic Breast Cancer Trial (Inetetamab, pyrotinib, chemo)
Not yet recruiting
- HER2-positive Recurrent/Metastatic Breast Cancer
- Inetetamab, pyrotinib, chemotherapy
- (no location specified)
Nov 16, 2022
Orthodontic Appliance Complication Trial in Baghdad (Enamel conditioning with a novel etchant paste)
Active, not recruiting
- Orthodontic Appliance Complication
- Enamel conditioning with a novel etchant paste
-
Baghdad, Alrusafaa, IraqHussain Qays Aswad
Mar 17, 2023
HER2 Mutant NSCLC Trial (Pyrotinib maleate)
Not yet recruiting
- HER2 Mutant Non-small Cell Lung Cancer
- Pyrotinib maleate
- (no location specified)
Jun 6, 2022
Glaucoma, Ocular Hypertensive Trial in Seoul (BRIDIN-plus Eye drops, Combigan Eye drops)
Completed
- Glaucoma
- Ocular Hypertensive
- BRIDIN-plus Eye drops
- Combigan Eye drops
-
Seoul, Seongnam, Bundang-gu, Korea, Republic ofSeungsoo Rho
Oct 9, 2023
Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +3 more
- Biopsy
- +7 more
- (no location specified)
Nov 9, 2023
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +24 more
- 18F-Fluoromisonidazole
- +4 more
-
La Jolla, California
- +15 more
Jan 3, 2023
Solid Tumor Trial (Pyrotinib Maleate, standard regimen)
Not yet recruiting
- Solid Tumor
- Pyrotinib Maleate
- standard regimen
- (no location specified)
Mar 9, 2022
HER2-positive or Mutated Advanced Colorectal Cancer Trial (Tislelizumab)
Not yet recruiting
- HER2-positive or Mutated Advanced Colorectal Cancer
- (no location specified)
May 16, 2022
Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)
Recruiting
- Metastatic Malignant Solid Neoplasm
- Unresectable Malignant Solid Neoplasm
- Biopsy
- +2 more
-
Boston, Massachusetts
- +2 more
Jan 25, 2023
Breast Cancer Trial (Pyrotinib Maleate Tablets)
Not yet recruiting
- Breast Cancer
- Pyrotinib Maleate Tablets
- (no location specified)
Jan 4, 2022
Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching
Not yet recruiting
- Gastrointestinal Cancer
- +2 more
- Avatrombopag
- Matching Placebo
-
Miami, Florida
- +1 more
Mar 6, 2023
Cough, Idiopathic Pulmonary Fibrosis Trial in Netherlands, United Kingdom, United States (Orvepitant Maleate, Placebo)
Recruiting
- Cough
- Idiopathic Pulmonary Fibrosis
- Orvepitant Maleate
- Placebo
-
Los Angeles, California
- +28 more
Aug 16, 2022
Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)
Active, not recruiting
- Recurrent Glioblastoma
- Bevacizumab
- +3 more
-
La Jolla, California
- +26 more
Jun 28, 2022
Healthy Volunteers Trial in Helsinki (Indacaterol maleate and glycopyrronium bromide, Ultibro Breezhaler with oral charcoal)
Completed
- Healthy Volunteers
- Indacaterol maleate and glycopyrronium bromide
- Ultibro Breezhaler with oral charcoal
-
Helsinki, FinlandCRST Helsinki Oy
Sep 27, 2021
Schizophrenia Trial in Shanghai (TPN-672)
Not yet recruiting
- Schizophrenia
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Dec 30, 2021
Hereditary Hemorrhagic Telangiectasia Trial in Toronto (Topical timolol maleate, saline drops)
Completed
- Hereditary Hemorrhagic Telangiectasia
- Topical timolol maleate
- placebo saline drops
-
Toronto, Ontario, CanadaSt. Michael's Hospital
Nov 19, 2021
NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Avitinib Maleate
- +13 more
-
Guangzhou, Guangdong, ChinaGuangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022
Infantile Hemangioma Trial in United States (0.25% Timolol Maleate Gel Forming Solution, 0.5% Timolol Maleate Gel Forming
Completed
- Infantile Hemangioma
- 0.25% Timolol Maleate Gel Forming Solution
- 0.5% Timolol Maleate Gel Forming Solution
-
Chicago, Illinois
- +11 more
Jan 18, 2022
Hepatocellular Carcinoma Trial in Greece, Israel, Italy (Milciclib maleate)
Completed
- Hepatocellular Carcinoma
- Milciclib maleate
-
Athens, Greece
- +13 more
Oct 11, 2021
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody
Active, not recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Anti-OX40 Agonist Monoclonal Antibody PF-04518600
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 25, 2022